'MAINRITSAN2-the future', with some doubts!
- PMID: 30315002
- DOI: 10.1136/annrheumdis-2018-214486
'MAINRITSAN2-the future', with some doubts!
Keywords: B cells; granulomatosis with polyangiitis; outcomes research; systemic vasculitis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: '"MAINRITSAN2-the future", with some doubts!' by Chattopadhyay et al.Ann Rheum Dis. 2019 Dec;78(12):e140. doi: 10.1136/annrheumdis-2018-214516. Epub 2018 Oct 26. Ann Rheum Dis. 2019. PMID: 30366944 No abstract available.
Comment on
-
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Ann Rheum Dis. 2018. PMID: 29695500 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
